Suggestions
Harry Leider
Senior Healthcare Executive
Harry Leider, MD, MBA is a seasoned healthcare executive with over 25 years of experience in prominent C-suite positions across various healthcare companies. He has held several key roles throughout his career, including:
-
Chief Medical Officer and Executive Vice President at Gelesis, a biotechnology company developing mechanotherapeutics to treat obesity and other chronic diseases related to the gastrointestinal pathway.13
-
Chief Medical Officer and Group Vice President at Walgreens from 2013 to 2018, where he provided executive leadership for clinical program development, quality assessment, health outcomes research, and health analytics.12
-
Chief Medical Officer and Senior Vice President at Ameritox, a national specialty laboratory providing medication monitoring services.2
-
Chief Medical Officer at XLHealth, a national population health company and Medicare health plan.2
-
Chief Medical Officer and Senior Vice President of Health Services at HealthNet, a large hospital-owned managed care organization in the Midwest.2
Dr. Leider's educational background includes an MD from the University of Pennsylvania School of Medicine and an MBA in Management from the University of Washington - Foster School of Business. He is known for his expertise in building high-performance teams and utilizing his business acumen, leadership skills, and clinical expertise to develop services that enhance the well-being of large populations at scale.
In addition to his executive roles, Dr. Leider has served on various boards and committees, including:
- Board member at MobileHelp2
- Senior Advisor at PureTech Health
- President, Chairman of the Board, and Faculty Member at the American Association of Physician Leadership
- Editorial board member of Physician Executive and the Journal of Population Health Management1
- Founding board member of the Disease Management Association of America (DMAA)1
Recently, Dr. Leider launched Leider Healthcare Solutions, providing "fractional" support to multiple innovative emerging healthcare companies as their Chief Medical Officer or Chief Strategy Officer.4


